APTINYX INC's ticker is APTX and the CUSIP is 03836N103. A total of 44 filers reported holding APTINYX INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $7,000 | -93.8% | 12,342 | -75.1% | 0.00% | – |
Q1 2022 | $112,000 | -7.4% | 49,647 | +10.1% | 0.00% | – |
Q4 2021 | $121,000 | +21.0% | 45,094 | +5.1% | 0.00% | – |
Q3 2021 | $100,000 | -37.9% | 42,900 | -24.4% | 0.00% | – |
Q2 2021 | $161,000 | +34.2% | 56,728 | +42.2% | 0.00% | – |
Q1 2021 | $120,000 | -25.0% | 39,896 | -14.0% | 0.00% | – |
Q4 2020 | $160,000 | +6.7% | 46,406 | +4.5% | 0.00% | – |
Q3 2020 | $150,000 | -15.3% | 44,400 | +4.4% | 0.00% | – |
Q2 2020 | $177,000 | -19.9% | 42,549 | -58.4% | 0.00% | – |
Q1 2020 | $221,000 | +5.7% | 102,170 | +67.2% | 0.00% | – |
Q4 2019 | $209,000 | -7.5% | 61,107 | -5.8% | 0.00% | – |
Q3 2019 | $226,000 | +5.1% | 64,851 | +0.6% | 0.00% | – |
Q2 2019 | $215,000 | +52.5% | 64,459 | +85.5% | 0.00% | – |
Q1 2019 | $141,000 | -60.1% | 34,741 | +62.9% | 0.00% | – |
Q4 2018 | $353,000 | -77.3% | 21,324 | -66.8% | 0.00% | – |
Q2 2018 | $1,554,000 | – | 64,301 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 3,290,079 | $1,836,000 | 1.19% |
ADAMS STREET PARTNERS LLC | 5,395,996 | $3,010,000 | 0.78% |
Bain Capital Life Sciences Investors, LLC | 8,891,758 | $4,961,000 | 0.58% |
Artal Group S.A. | 6,116,493 | $3,412,000 | 0.18% |
Frazier Life Sciences Management, L.P. | 1,883,244 | $1,051,000 | 0.10% |
NORTHWESTERN UNIVERSITY | 109,280 | $61,000 | 0.06% |
DCF Advisers, LLC | 48,529 | $27,000 | 0.02% |
Meridian Wealth Management, LLC | 192,000 | $107,000 | 0.01% |
Orbimed Advisors | 538,500 | $300,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 157,641 | $88,000 | 0.00% |